Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Tenaya Therapeutics, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives of the several underwriters named therein valued at approximately $75.0 million (effective 2022-11-16).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives of the several underwriters named therein
- Value
- approximately $75.0 million
- Effective
- 2022-11-16
Exact text from the filing
On November 16, 2022, Tenaya Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives (the “Representatives”) of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 22,613,307 shares of the Company’s common stock, par value $0.0001 per share, at a price to the public of $2.60 per share (the “Underwritten Shares”) and pre-funded warrants (the “Pre-Funded Warrants”) to purchase 6,236,693 shares of the Company’s common stock at a price to the public of $2.599 per underlying share.
View on SEC.gov